A METHOD AND CELL FOR REDUCING DINITROGEN TO AMMONIA

    公开(公告)号:US20250122631A1

    公开(公告)日:2025-04-17

    申请号:US18567599

    申请日:2022-05-25

    Abstract: The invention provides a method of reducing dinitrogen to produce ammonia, the method comprising: contacting a cathode of an electrochemical cell with an electrolyte comprising: (i) a metal cation selected from the group consisting of lithium, magnesium, calcium, strontium, barium, zinc, aluminium, vanadium and combinations thereof, wherein the metal cation is present at a concentration of greater than 0.5 mol/L in the electrolyte, (ii) one or more anions comprising at least one negative ion selected from the group consisting of fluorinated sulfonyl imides, fluorinated sulfonyl methides and combinations thereof, (iii) a proton carrier; and (iv) optionally, at least one phosphonium cation, wherein the combined amount of the metal cation and the optional at least one phosphonium cation is greater than 1 mol/L in the electrolyte; supplying dinitrogen to the electrochemical cell for cathodic reduction; and applying a potential at the cathode sufficient to reduce the dinitrogen, thereby producing ammonia.

    METHOD OF VIRAL INHIBITION
    2.
    发明申请

    公开(公告)号:US20250108018A1

    公开(公告)日:2025-04-03

    申请号:US18930615

    申请日:2024-10-29

    Abstract: This invention relates to methods of treating or preventing viral infections caused by flaviviruses, such as dengue virus, yellow fever virus, West Nile virus or Japanese encephalitis virus or infections caused by Chikungunya virus (CHIKV). The methods involve the administration of retinoic acid analogues to subjects who have, are suspected of having a flavivirus infection or infection with CHIKV, or to those who are at risk of becoming infected with a flavivirus or becoming infected with CHIKV.

    Inhaler
    8.
    外观设计
    Inhaler 有权

    公开(公告)号:USD1019932S1

    公开(公告)日:2024-03-26

    申请号:US29765322

    申请日:2021-01-07

    Abstract: FIG. 1 is a top perspective view of an inhaler showing our new design;
    FIG. 2 is a bottom perspective view thereof;
    FIG. 3 is a top plan view thereof;
    FIG. 4 is a front elevational view thereof;
    FIG. 5 is a rear elevational view thereof;
    FIG. 6 is a bottom plan view thereof; and,
    FIG. 7 is a left side elevational view thereof, the right side elevational view being a mirror image thereof.
    The broken lines in the figures depict portions of the inhaler which form no part of the claimed design.
    The black areas in the figures depict portions of the inhaler having a contrasting surface appearance, such as contrasting color, including black.

Patent Agency Ranking